Institutional investors hold a majority ownership of GRFS through the 62.47% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2016, these large investors purchased a net $7.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HARDING LOEVNER LP Bought 6.4 Million shares of Grifols SA
FMR INVESTMENT MANAGEMENT (UK) L... Bought 206.7 Thousand shares of Grifols SA